✦ LIBER ✦

IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B

✍ Scribed by Lampertico, Pietro; Viganò, Mauro; Cheroni, Cristina; Facchetti, Floriana; Invernizzi, Federica; Valveri, Vincenza; Soffredini, Roberta; Abrignani, Sergio; De Francesco, Raffaele; Colombo, Massimo

Book ID: 120489418
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 373 KB
Volume: 57
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.25749

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Outcome after Hepatitis B Surf

Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Hepatitis B and D genomes in hepatitis B

Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C

✍ Sara González; Sonia Navas; Antonio Madejón; Javier Bartolomé; Inmaculada Castil 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

## Abstract Hepatitis B and hepatitis D viral genomes were tested by nested polymerase chain reaction in the serum and liver of 69 hepatitis B surface antigen (HBsAg) negative, anti‐hepatitis C virus (HCV) positive patients (47 with HCV RNA and 22 without HCV RNA). Serum hepatitis B virus (HBV) DNA

1397 SINGLE NUCLEOTIDE POLYMORPHISMS ASS

1397 SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH SEROCLEARANCE OF HEPATITIS B SURFACE ANTIGEN IN CHRONIC HEPATITIS B PATIENTS WITH SEROCLEARANCE OF HBV DNA

✍ Yang, H.-I.; Lee, M.-H.; Liu, J.; Lee, C.-Y.; Lin, Y.-R.; Jen, C.-L.; Chien, Y.- 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Comparison of hepatitis B surface antige

Comparison of hepatitis B surface antigen and e antigen in predicting liver histology in hepatitis B e antigen-positive chronic hepatitis B patients

✍ Wang, Hong; Yan, Rong; Zhou, Yin; Wang, Ming Shan; Ruo, Guo Qin; Cheng, Mei Juan 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 502 KB

Efficacy of lamivudine in patients with

Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

419 QUANTITATIVE SERUM HEPATITIS B SURFA

419 QUANTITATIVE SERUM HEPATITIS B SURFACE ANTIGEN IMPROVES PREDICTABILITY OF HBVDNA SEROCLEARANCE BUT NOT HBeAg SEROCLEARANCE IN CHRONIC HEPATITIS B PATIENTS

✍ Liu, J.; Yang, H.-I.; Lee, M.-H.; Jen, C.-L.; Lu, S.-N.; Wang, L.-Y.; You, S.-L. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB